The effect of human mobility and control measures on the COVID-19 epidemic in China.

A new interesting article has been published in Science. 2020 Mar 25. pii: eabb4218. doi: 10.1126/science.abb4218. [Epub ahead of print] and titled:

The effect of human mobility and control measures on the COVID-19 epidemic in China.

Authors of this article are:

Kraemer MUG, Yang CH, Gutierrez B, Wu CH, Klein B, Pigott DM; Open COVID- Data Working Group, du Plessis L, Faria NR, Li R, Hanage WP, Brownstein JS, Layan M0, Vespignani A, Tian H, Dye C, Pybus OG, Scarpino SV.

A summary of the article is shown below:

The ongoing COVID-19 outbreak expanded rapidly throughout China. Major behavioral, clinical, and state interventions have been undertaken to mitigate the epidemic and prevent the persistence of the virus in human populations in China and worldwide. It remains unclear how these unprecedented interventions, including travel restrictions, affected COVID-19 spread in China. We use real-time mobility data from Wuhan and detailed case data including travel history to elucidate the role of case importation on transmission in cities across China and ascertain the impact of control measures. Early on, the spatial distribution of COVID-19 cases in China was explained well by human mobility data. Following the implementation of control measures, this correlation dropped and growth rates became negative in most locations, although shifts in the demographics of reported cases were still indicative of local chains of transmission outside Wuhan. This study shows that the drastic control measures implemented in China substantially mitigated the spread of COVID-19.Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

Check out the article’s website on Pubmed for more information:



This article is a good source of information and a good way to become familiar with topics such as: COVID-19; SARS-COV-2; 2019-nCoV; Coronavirus.


New Research Kits from MOLECULAR DEPOT


New Antibodies from MOLECULAR DEPOT


New Proteins from MOLECULAR DEPOT


New Chemicals from MOLECULAR DEPOT

Molecular Depot

Your specialty peptide, proteins, antibodies and chemical compounds store.